Determining Individualized Cancer Therapy in Pancreatic Cancer

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

December 4, 2023

Primary Completion Date

August 1, 2028

Study Completion Date

August 1, 2033

Conditions
Pancreatic Neoplasms
Interventions
OTHER

Targeted Therapy

Approved interventions based on the subject's genomic profile will be provided to investigators for consideration for anti-tumor therapy.

Trial Locations (1)

53226

RECRUITING

Froedtert Hospital and the Medical College of Wisconsin, Milwaukee

All Listed Sponsors
lead

Medical College of Wisconsin

OTHER